The steroid era of startups is over - Here's what 8 top VCs think will happen next
Business Insider
The game has changed.
In April, venture capitalist Bill Gurley wrote an essay crystallizing what many venture capitalists had been talking about for months.
Essentially, too many companies have taken too much money at unsupportable valuations. A lot of the money they raised came with huge caveats that would protect late stage investors.
A lot of these companies now have limited options, Gurley wrote. They can't raise more money from the private markets because their last rounds came with such strict conditions. They can't go public because their numbers aren't good enough.
"In the steroid era of baseball, a lot of people were hitting 30 home runs and the perception was that wasn't that difficult. Well the reality is almost no one ever hits 30 home runs without using special supplements and the same thing is true [for startups]," says Keith Rabois, a partner at Khosla Ventures. "And as you deprive companies or take away the steroids, it turns out that very few people can build transformative and disruptive companies that are worth billions of dollars."
So what happens next?
Business Insider spoke to 8 leading venture capitalists about what the tech landscape looks like from their point of view - and where startups go from here.
The answer involves a lot of pain for founders, employees, and investors in the years to come.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- An Ambani disruption in OTT: At just ₹1 per day, you can now enjoy ad-free content on JioCinema
- Vegetable prices to remain high until June due to above-normal temperature
- RBI action on Kotak Mahindra Bank may restrain credit growth, profitability: S&P
- 'Vote and have free butter dosa': Bengaluru eateries do their bit to increase voter turnout
- Reliance gets thumbs-up from S&P, Fitch as strong earnings keep leverage in check
- Realme C65 5G with 5,000mAh battery, 120Hz display launched starting at ₹10,499